Idiopathic Renal Infarction and Anticoagulation.

Abstract

Idiopathic renal infarction (iRI) is rare and the pathophysiology is not well understood.1 There is no consensus treatment strategy for iRI, because previous studies have not reported long-term outcomes based on therapeutic intervention.2–15 We sought to determine if anticoagulation or nonanticoagulation was associated with a higher incidence of recurrent arterial thrombosis, de novo venous thrombosis, bleeding event, or development of long-term hypertension, proteinuria, or chronic kidney disease (CKD).